Prof. Çağatay Arslan, M.D.
MedicalPoint Izmir Hospital
Medical Oncology
Senology Center
Senology Center
Request Call Back
Education and Expertise
- ANKARA UNIVERSITY FACULTY OF MEDICINE
Diseases
- Brain Tumors
- Gastrointestinal Cancers
- Genitourinary Cancers
- Lymphoma
- Malign Melanoma
- Breast Cancer
- Sarcomas
Experience
- Internal Medicine Specialist; Süleyman Demirel University Medical Faculty Hospital Internal Medicine Department
- Medical Oncology Specialist; Hacettepe University Faculty of Medicine Oncology Hospital, Department of Medical Oncology
Professional Memberships
- ESMO (European Society for Medical Oncology), full membership
- Turkish Medical Oncology Association, full membership
Research Publications
- Ç. Arslan, Ö. Dizdar, K. Altundağ. Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update. Expert Opin Pharmacother 1643-58 pp., 2014. DOI:10.1517/14656566.2014.929664
- Ç. Arslan, M. Işık, G. Güler, İ. Kulaç, M. Solak, B. Türker, Y. Özışık, K. Altundağ. “Does Androgen Receptor Have a Prognostic Role in Patients with Estrogen/Progesterone-Negative and c-erb-2-Positive Breast Cancer”, Am Surg (ISI), 992-999 pp., 2012.
- Ç.Arslan, S.Aksoy, Ö.Dizdar, M.Kurt, N.Guler, Y.Özışık, İ.Güllü, K.Altundağ, “Increased Mean Corpuscular Volume of Erythrocytes during Capecitabine Treatment; Simple Surrogate Marker for Clinical Response”, Tumori (ISI) , 711-716 pp., 2011 , DOI: 10.1700/1018.11086
- Ç.Arslan, S.Aksoy, Ö.Dizdar, D.Ş.Dede, H.Harputluoğlu, K.Altundağ, “Zoledronic acid and atrial fibrillation in cancer patients.”, Supportive Care in Cancer (ISI) , 425-430 pp., 2011 , DOI: 10.1007/s00520-010-0868-z
- Ç.Arslan, E.Özdemir, S.Aksoy, D.Ş.Dede, E.Doğan, Y.Özışık, K.Altundağ, “Secondary hematological malignancies after treatment of early breast cancer patients.”, Journal of BUON (ISI) , 744-750 pp., 2011
- Ç.Arslan, Ö.Dizdar, K.Altundağ, “Emerging drugs in metastatic breast cancer: An update.”, Expert Opinion on Emerging Drugs (ISI) , 647-667 pp., 2011 , DOI: 10.1517/14728214.2011.640672
- Ç. Arslan, Ş.Yalçın. Current and future systemic treatment options in metastatic pancreatic cancer.J Gastrointest Oncol. 280-95 pp., 2014.DOI: 10.3978/j.issn.2078-6891.2014.030.
- “Ç. Arslan, R. Uslu. Secondary haematological malignancies in the BCIRG 001 study.
Lancet Oncol. e87-8 pp., 2013 DOI: 10.1016/S1470-2045(13)70015-9.” - Ç.Arslan, E.Sarı, S.Aksoy, K.Altundağ, “Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature.”, Expert Opinion on Therapeutic Targets (ISI) , 21-30 pp., 2011 , DOI: 10.1517/14656566.2011.53726
